Tue.Sep 06, 2022

article thumbnail

The 2022 PharmaVoice 100

PharmaVoice

From standout executives to R&D pioneers — this year’s class of honorees is defining the next era of leadership.

137
137
article thumbnail

NICE says no to Lynparza in prostate cancer, creating UK access divide

pharmaphorum

NICE has said it is unable to recommend NHS use of AstraZeneca’s Lynparza for some patients with prostate cancer, after failing to reach an agreement on price with the drugmaker. The health technology assessment (HTA) authority said that the PARP inhibitor “is not cost-effective at its current price” as a treatment for BRCA-positive prostate cancer that has spread to other parts of the body and relapsed after prior hormonal therapy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

US FDA grants Orphan Drug status to Avacta’s drug for soft tissue sarcoma

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has awarded Orphan Drug Designation (ODD) to Avacta Group’s lead pre|CISION drug candidate, AVA6000, to treat soft tissue sarcoma. Updated using the pre|CISION technology, AVA6000 is a kind of generic chemotherapy doxorubicin. This approach aids the therapy to be activated mainly in the tumour, sparing healthy tissue from exposure.

article thumbnail

Clinical registry data, a valuable source of real-world data

PharmaVoice

Real-world data (RWD) from clinical drug registries can and should be used throughout the drug development lifecycle. At all stages, registries ensure that assumptions about the current standard of care are accurate and evidence-based.

98
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Intas Pharmaceuticals Ltd-Walk-In Drive for Manufacturing/ Packaging Department On 9th Sept’ 2022

Pharma Pathway

Intas Pharmaceuticals Ltd-Walk-In Drive for Manufacturing/ Packaging Department On 9th Sept’ 2022. Job Description. Company Profile: INTAS Pharmaceutical is a leading, vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company. Intas is committed to challenging the unmet medical and societal needs through a comprehensive pharmaceutical value chain spanning across the world.

article thumbnail

Entrepreneurs: Vincent Keunen

PharmaVoice

With his unique platform, the has built a bridge between patients, physicians and researchers around the world.

More Trending

article thumbnail

Innovators: Dr. Stephen Dale

PharmaVoice

The CMO at Kura Oncology, a clinical-stage biopharma company, is charting a new course to deliver on the promise of precision medicine in oncology.

article thumbnail

A Strategy to Address the Price Issue in Medical Sales

MedReps

It’s not unusual for a medical sales representative, regardless of their product niche, to hear price negotiations from their clients. After all, everyone wants the best price, even if that involves taking a mere 5% off of the cost. Even the largest hospitals and clinics have budgets and it’s up to your clients to adhere to them. With that said, how do you address the price issue when it comes up?

article thumbnail

Pleco raises €17m for tumour microenvironment drug

pharmaphorum

Pleco Therapeutics has closed a first-round financing, raising just over €17 million that it says will fund the development of its lead therapy for acute myeloid leukaemia (AML) through to regulatory filings in the US and EU. The Nijmegen, Netherlands-based biotech was founded in 2018 to develop therapies designed to change the balance of protein expression within the tumour ‘microenvironment’, which can defend cancers against the immune system, and is increasingly becoming a source

Leads 80
article thumbnail

Disrupters: Trishna Bharadia

PharmaVoice

As a patient advocate, The Spark Global’s owner is transforming how pharma companies approach patient centricity.

Pharma 98
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

UK health leaders warn new PM Liz Truss of crisis-in-waiting

pharmaphorum

New UK Prime Minister Liz Truss needs to take immediate action to prevent the NHS spiralling out of control this winter, according to groups representing healthcare workers. Truss takes power as the NHS is in “its worst state in living memory,” according to NHS Confederation chief executive Matthew Taylor, who says it is vital that the health service becomes a “top three” priority for the new administration as it grapples with an estimated real-terms funding cut of £9.4 b

article thumbnail

PhoreMost in drug target discovery collaboration with Roche

PharmaTimes

PhoreMost will use Siteseeker platform to identify novel targets for Roche’s discovery programmes

95
article thumbnail

Bayer sets out a proposed basis for science-based self-care products

pharmaphorum

The healthcare sector has a “moral imperative” to help people navigate the self-care industry, says pharma giant. Recent years have seen an explosion in the “self-care” industry, a sector that was worth an estimated $4.9 billion in 2019. But in a world of fake news and influencer-led trends, it’s the healthcare sector’s responsibility to ensure people have the knowledge they need to sort the wheat from the chaff.

article thumbnail

Leading pharmaceutical logistics and pharma supply chain companies

Pharmaceutical Technology

The pharmaceutical supply chain is a global and complex network that includes a wide range of stakeholders such as pharmaceutical manufacturers, wholesale distributors, and pharmacy benefit managers (PBM), to ensure efficient and timely delivery of medications to the patients. Hospitals, clinics, pharmacies, wholesalers of medical products and other health centres are catered by pharmaceutical logistics that include handling activities such as procurement, warehousing, and inventory management,

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

BioInnovation Institute reveals new cohort entering Venture Lab programme

PharmaTimes

Group consists of nine ventures plus corporate-sponsored innovation projects from Novo Nordisk

83
article thumbnail

Drug Solutions Podcast: How Pfizer Views Partnering and Investing for Emerging Therapies

PharmaTech

How Pfizer’s external-facing research and development scientists uncover the most promising emerging therapy concepts and ideas in the pharmaceutical landscape.

article thumbnail

Aculife Healthcare Pvt. Ltd-Walk-In Interview for Freshers for Apprentice On 15th Sept’ 2022

Pharma Pathway

Aculife Healthcare Pvt. Ltd-Walk-In Interview for Freshers for Apprentice On 15th Sept’ 2022. Job Description. Walk-In Interview for Freshers for Apprentice On 15th Sept’ 2022 @ Aculife Healthcare Pvt. Ltd. Job Role: Apprentice Trainee. B.Sc/ M.Sc. B.Pharm/ M.Pharm. B.Com/ M.Com/ BA/ MA. Fitter Electrical / Turner. Wireman/ Welder/ COPA.

article thumbnail

How Bad Data Affects Revenue

Scott’s Directories

Many business owners are not aware that bad data can affect their revenue. According to statistics from Experian Data Quality, an average company loses about 12% of its revenue because of bad data. Bad data can cause business organizations to pay heavy fines. For example, many companies have been fined for sending text messages to mobile numbers that were reassigned to a new user.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Business optimism improved in August 2022: Poll

Pharmaceutical Technology

Business optimism improved in August 2022 compared to July 2022, according to an ongoing poll by Verdict, despite businesses expressing concern over inflation, particularly in raw materials and energy costs. Verdict has been conducting the poll to study the trends in business optimism during COVID-19 as reflected by the views of companies on their future growth prospects amid the pandemic.

article thumbnail

Magnus Medical Receives FDA Clearance for the SAINT Neuromodulation System

Legacy MEDSearch

Magnus Medical, Inc. , a medical device company and developer of brain stimulation technology for treatment of neuropsychiatric disorders, announced it received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for the SAINT TM Neuromodulation System for the treatment of major depressive disorder (MDD) in adults who have failed to achieve satisfactory improvement from prior antidepressant medications in the current episode.

Medical 52
article thumbnail

Scott Burrows, Motivational Safety Speaker

Scott Burrows

Safety is not about “Hybrid” The business world, it seems, is obsessed with the hybrid workplace. As a motivational safety speaker who once “worked with his hands,” I see the obsession with the office workplace as perhaps a bit classist.

Safety 52
article thumbnail

Illumina eyeing future of Grail as EU shoots down merger

pharmaphorum

The EU has blocked the merger of Illumina and Grail, saying the deal would stifle innovation in blood-based diagnostics for cancer diagnostics, just days after a bid by the US authorities to do likewise was blocked in the courts. The European Commission said in a statement this afternoon that Illumina had not provided enough assurances to address its concerns that the $7.1 billion merger would squeeze other players in the liquid biopsy category out of the market.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Legacy Leaders: Dr. Steven Steinhubl

PharmaVoice

The chief medical officer at physIQ is working at the intersection of healthcare, clinical trials and technology to deliver better, faster and more accurate treatments to patients around the globe.

article thumbnail

UK pharma industry IT recruitment activity rises 3.3% in August 2022

Pharmaceutical Technology

The UK’s pharma industry registered a 3.3% rise in IT hiring activity in August 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring is decreased by 1.6% in August 2022 when compared with July 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 4.27% share in August 2022, recording an increase of 0.13% over the last three-month average share.

article thumbnail

CVS beats out Amazon in bidding for Signify Health

pharmaphorum

Pharmacy chain CVS has stepped up its drive into the wider healthcare market with an agreement to buy at-home care and technology provider Signify Health for around $8 billion – reportedly besting Amazon in a bidding war for the group. CVS is paying $30.50 per share for Texas-based Signify, which operates a network of more than 10,000 clinicians across all 50 states, delivering care to patients with the help of a digital health and analytics platform to Medicare Advantage and other federal manag

article thumbnail

Switzerland’s pharma industry IT recruitment activity drops 2.3% in August 2022

Pharmaceutical Technology

Switzerland’s pharma industry registered a 2.3% drop in IT hiring activity in August 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring is decreased by 1.62% in August 2022 when compared with July 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 2.74% share in August 2022, recording a decrease of 0.53% over the last three-month average share.

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Innovators: Shanthi Ganeshan

PharmaVoice

The longtime regulatory pro has used innovative strategies to deliver emerging oncology therapies to patients from her position as head of regulatory affairs at Stemline.

article thumbnail

US pharma industry IT recruitment activity drops 1.4% in August 2022

Pharmaceutical Technology

The US’s pharma industry registered a 1.4% drop in IT hiring activity in August 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring increased by 2.81% in August 2022 when compared with July 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 1.84% share in August 2022, recording a decrease of 0.05% over the last three-month average share.

article thumbnail

Entrepreneurs: WeiQing Zhou

PharmaVoice

The COO has launched two jewels in the biotech world that complement each other while serving broader innovation goals throughout the industry.

52
article thumbnail

AstraZeneca’s IT hiring activity declines 5.4% in August 2022

Pharmaceutical Technology

UK-based company AstraZeneca’s IT hiring declined 5.4% in August 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity declined by 8.49% in August 2022 when compared with July 2022. IT jobs claimed an 8.47% share in the company’s total hiring activity in August 2022, and recorded a 0.24% growth over the last three-month average share.

Leads 52
article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.